** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)

Public Alert No. 17/2025 – Alert on Falsified Batches of Healmoxy Capsules 500mg found in Cameroon and Central African Republic (CAR)

The National Agency for Food and Drug Administration and Control (NAFDAC) hereby notifies the public of the falsified batches of Healmoxy Capsules 500mg, manufactured by Maxheal Pharmaceuticals (India), with batch numbers 023011 and H02605, found in Cameroon and H02605 in the Central African Republic (CAR). The brand is registered and imported by Nkoyo Chemist, located […]

Public Alert No. 16/2025 – Alert on Counterfeit/Falsified Rosprazole (Rabeprazole  Injection) 20mg

The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about a falsified Rosprazole (Rabeprazole Injection) 20mg with a fake NAFDAC Reg. No. C4-0150. Genuine Rabeprazole Injection (20mg) is a proton pump inhibitor (PPI) used in hospital settings to manage various acid-related gastrointestinal conditions especially Gastroesophageal reflux disease (GERD), to […]

Update on the Ongoing Enforcement Operation on the Open Drug Markets in Nigeria

The public will recall the recent enforcement operation in three Open Drug Markets (Idumota, Aba and Onitsha) in the country where banned, expired, falsified, and substandard narcotic medicines worth more than a trillion Naira were evacuated. Between 9th February and 27th March 2025, NAFDAC conducted a raid operation to remove unregistered, expired, banned, diverted donation […]

Public Alert No. 015/2025 – Recall of Substandard Juhel Folic Acid Tablet

The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the recall of one batch of Juhel Folic acid 5mg x1000 tablet. The product was discovered during the Risk Based Post Marketing Surveillance (PMS) sampling in February 2025 and laboratory analysis indicates that the product is substandard. According to […]

Public Alert No. 14/2025 – Alert on the Declaration of Over 100 Medications as Substandard by Indian Authorities

The National Agency for Food and Drug Administration and Control (NAFDAC) is in receipt of information regarding drugs that were declared Not of Standard Quality(NSQ) by the Central Drugs Standard Control Organization (CDSCO) India. This declaration follows result of analyzed drug samples picked from sales/distribution point, with outcome of Not of Standard Quality (NSQ). Some […]

Press Briefing on Who Pre-Qualification of Afriject 0.5ml Autodisable Syringes Manufactured by Afrimedical Manufacturing & Supplies Ltd. Ibafo, Ogun State.

PROTOCOLS The National Agency for Food and Drug Administration and Control (NAFDAC) is pleased to announce that Afrimedical Manufacturing and Supplies Ltd, Ogun State has achieved WHO Prequalification of a medical device 0.5 ml auto disable syringe after an arduous process, guided by NAFDAC and heavy investment that was made by Afrimedical to achieve this […]

Implementation of ICH E6(R3) and ICH M13a Guidelines

NAFDAC WORKSHOP ON ICH E6(R3) AND ICH M13A GUIDELINES AND THEIR IMPLEMENTATION The National Agency for Food and Drug Administration and Control (NAFDAC), in collaboration with the International Council for Harmonization (ICH), successfully conducted a training workshop on the implementation of ICH E6(R3) Good Clinical Practice (GCP) and ICH M13A Bioequivalence for Immediate-Release Oral Dosage […]

International Council for Harmonization (ICH) E6(R3) Good Clinical Practice Training

Executive Summary for International Council for Harmonization (ICH) E6(R3) Good Clinical Practice Training Overview:The National Agency for Food and Drug Administration and Control (NAFDAC) in collaboration with the International Council for Harmonization (ICH), organized an ICH E6(R3) training, which held from April 7 to 9, 2025 at the Marriott hotel, Ikeja, Lagos, Nigeria.  This was […]